文献速递产科母胎医学

期待治疗管理剖宫产瘢痕妊娠的结局:系统综述与Meta分析

Outcome of Cesarean scar pregnancy managed expectantly: systematic review and meta-analysis.
PubMed 文献 · Ultrasound Obstet Gynecol · 2018-01-01

该系统综述与Meta分析纳入17项研究共69例期待治疗的剖宫产瘢痕妊娠(CSP),按诊断时有无胚胎/胎儿心跳分层。有心脏活动者中,无并发症流产13.0%,需医疗干预20.0%,早中孕期子宫破裂9.9%,需子宫切除15.2%;进展至晚孕期者严重出血39.2%,分娩时异常侵袭性胎盘(AIP)74.8%,其中胎盘穿透69.7%。无心脏活动者无并发症流产69.1%,需手术或药物干预30.9%,早孕期子宫破裂13.4%,无子宫切除。

要点

  • CSP伴胚胎/胎儿心跳者期待治疗母体并发症负担高,包括严重出血、早期子宫破裂、子宫切除和严重AIP。
  • CSP无心跳者期待治疗母体需干预的并发症可能性较低,但仍建议密切监测以避免不良母体结局。
  • 部分CSP可进展至或接近足月,作者据此质疑终止妊娠是否应作为唯一治疗选择。

核心结论

  • CSP伴胚胎/胎儿心跳者期待治疗与严重出血、早期子宫破裂、子宫切除和严重AIP等高母体并发症负担相关。
  • 相当比例CSP可进展至或接近足月,作者质疑终止妊娠是否应作为唯一治疗选择。
  • CSP无心跳者期待治疗因需干预的母体并发症可能性较低而可能是合理选择,但建议密切监测以避免不良母体结局。

研究设计与样本

  • 系统综述与Meta分析,检索MEDLINE、EMBASE和ClinicalTrials.gov数据库,并手工检索相关文章和综述的参考文献列表。
  • 共纳入17项研究、69例期待治疗的CSP,其中52例有胚胎/胎儿心跳、17例无胚胎/胎儿心跳。
  • 采用随机效应模型对比例进行Meta分析,按诊断时有无胚胎/胎儿心跳分层。

主要发现

  • 有胚胎/胎儿心跳者:无并发症流产13.0%(95%CI 3.8-26.7%),需医疗干预20.0%(95%CI 7.1-37.4%)。
  • 有胚胎/胎儿心跳者:早中孕期子宫破裂9.9%(95%CI 2.9-20.4%),需子宫切除15.2%(95%CI 3.6-32.8%)。
  • 有胚胎/胎儿心跳者:40例(76.9%,95%CI 65.4-86.5%)进展至晚孕期,其中严重出血39.2%(95%CI 15.4-66.2%)。
  • 有胚胎/胎儿心跳者:分娩时手术或病理诊断AIP 74.8%(95%CI 52.0-92.1%),其中胎盘穿透69.7%(95%CI 42.8-90.1%)。
  • 无胚胎/胎儿心跳者:无并发症流产69.1%(95%CI 47.4-87.1%),流产时或流产后即刻需手术或药物干预30.9%(95%CI 12.9-52.6%);早孕期子宫破裂13.4%(95%CI 2.7-30.3%),无子宫切除。

关键数值与推荐

  • 有胚胎/胎儿心跳的CSP期待治疗:无并发症流产13.0%(95%CI 3.8-26.7%),需医疗干预20.0%(95%CI 7.1-37.4%)。
  • 有胚胎/胎儿心跳的CSP期待治疗:早中孕期子宫破裂9.9%(95%CI 2.9-20.4%),子宫切除15.2%(95%CI 3.6-32.8%)。
  • 有胚胎/胎儿心跳的CSP期待治疗:进展至晚孕期76.9%(95%CI 65.4-86.5%),严重出血39.2%(95%CI 15.4-66.2%)。
  • 有胚胎/胎儿心跳的CSP期待治疗:AIP 74.8%(95%CI 52.0-92.1%),胎盘穿透69.7%(95%CI 42.8-90.1%)。
  • 无胚胎/胎儿心跳的CSP期待治疗:无并发症流产69.1%(95%CI 47.4-87.1%),需干预30.9%(95%CI 12.9-52.6%),早孕期子宫破裂13.4%(95%CI 2.7-30.3%),无子宫切除。

临床怎么用

  • 作者认为,CSP无心跳者期待治疗可能是合理选择,但建议密切监测以避免不良母体结局。
  • 作者质疑终止妊娠是否应作为CSP伴心跳者的唯一治疗选择。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To explore the outcome in women managed expectantly following the diagnosis of Cesarean scar pregnancy (CSP). METHODS: An electronic search of MEDLINE, EMBASE and ClinicalTrials.gov databases was performed utilizing combinations of relevant medical subject headings for 'Cesarean scar pregnancy' and 'outcome'. Reference lists of relevant articles and reviews were hand-searched for additional reports. Observed outcomes included: severe first-trimester vaginal bleeding; clinical symptoms (abdominal pain, vaginal bleeding) requiring treatment; uncomplicated miscarriage; complicated miscarriage requiring intervention; first- or second-trimester uterine rupture or hysterectomy; third-trimester bleeding, uterine rupture or hysterectomy; maternal death; incidence of abnormally invasive placenta (AIP); prevalence of placenta percreta; ultrasound signs suggestive of AIP; and live birth. Meta-analyses of proportions using a random-effects model were used to combine data. Cases were stratified based on the presence or absence of embryonic/fetal heart activity at the time of diagnosis. RESULTS: A total of 17 studies (69 cases of CSP managed expectantly, 52 with and 17 without embryonic/fetal heart beat) were included. In women with CSP and embryonic/fetal heart activity, 13.0% (95% CI, 3.8-26.7%) experienced an uncomplicated miscarriage, while 20.0% (95% CI, 7.1-37.4%) required medical intervention. Uterine rupture during the first or second trimester of pregnancy occurred in 9.9% (95% CI, 2.9-20.4%) of cases, while hysterectomy was required in 15.2% (95% CI, 3.6-32.8%) of all cases. Forty (76.9% (95% CI, 65.4-86.5%)) women progressed to the third trimester of pregnancy, of whom 39.2% (95% CI, 15.4-66.2%) experienced severe bleeding. Finally, 74.8% (95% CI, 52.0-92.1%) had a surgical or pathological diagnosis of AIP at delivery and around two-thirds (69.7% (95% CI, 42.8-90.1%)) of them had placenta percreta. In women with CSP but no embryonic/fetal cardiac activity, an uncomplicated miscarriage occurred in 69.1% (95% CI, 47.4-87.1%) of cases, while surgical or medical intervention during or immediately after miscarriage was required in 30.9% (95% CI, 12.9-52.6%). Uterine rupture during the first trimester of pregnancy occurred in 13.4% (95% CI, 2.7-30.3%) of cases, but hysterectomy was not required in any case. CONCLUSIONS: CSP with positive embryonic/fetal heart activity managed expectantly is associated with a high burden of maternal morbidity including severe hemorrhage, early uterine rupture, hysterectomy and severe AIP. Despite this, a significant proportion of pregnancies complicated by CSP may progress to, or close to, term, thus questioning whether termination of pregnancy should be the only therapeutic option offered to these women. Expectant management of CSP with no cardiac activity may be a reasonable option in view of the low likelihood of maternal complications requiring intervention, although close surveillance is advisable to avoid adverse maternal outcome. Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Calì G, Timor-Tritsch IE, Palacios-Jaraquemada J, et al. Outcome of Cesarean scar pregnancy managed expectantly: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2018. PMID: 28661021. doi:10.1002/uog.17568

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。